Overview: Glyceric Acid TestIntroduction: The Glyceric Acid Test tests for elevated glyceric acid to diagnose metabolic disorders like D-glyceric aciduria, causing developmental delays or seizures, aiding in diagnosis. Affecting 1 in 100,000 people, D-glyceric aciduria poses diagnostic challenges due to rare presentation. Following 2023 American College of Medical Genetics (ACMG) guidelines, it uses GC-MS for high accuracy, supporting biochemistry screening. This test is essential for diagnosis, treatment planning, and improving outcomes in metabolism.
Other Names: Glyceric Acid Level Test, D-Glyceric Aciduria Assay.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic reliability.
Historical Milestone: Metabolic acid testing began in the 1970s with research by Duran, who identified glyceric acid in aciduria. GC-MS advancements in the 1990s by Agilent improved detection, surpassing earlier TLC methods.
Purpose: Measures glyceric acid levels to diagnose D-glyceric aciduria, guides dietary or supportive therapy, and evaluates patients with seizures, aiming to manage symptoms.
Test Parameters: Glyceric acid levels
Pretest Condition: No special preparation required. Collect urine or plasma. Report history of metabolic issues.
Specimen: Urine (sterile container, 5-20 mL), Plasma (NaHep, 2-4 mL); 10 mL urine in sterile container. Transport in a biohazard container.
Sample Stability at Room Temperature: 4 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: 1 month
Medical History: Document developmental delay or seizures. Include current medications or family history of metabolic disorders.
Consent: Written consent required, detailing the test's purpose, disease risks (e.g., neurodegeneration), and sample collection risks.
Procedural Considerations: Uses GC-MS to measure glyceric acid, requiring labs with gas chromatographs. Results available in 2-3 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample degradation or contamination can affect results. Medications may not affect results but require correlation.
Clinical Significance: Elevated glyceric acid confirms aciduria, guiding therapy. Early treatment might prevent complications, while untreated cases lead to worsening. Normal levels may require genetic tests.
Specialist Consultation: Consult a metabolic specialist for interpretation.
Additional Supporting Tests: Urine organic acid analysis, enzyme assay, or genetic panel to confirm diagnosis.
Test Limitations: Specific to glyceric acid; correlation with symptoms needed. False negatives possible with low levels.
References: ACMG Guidelines, 2023; Journal of Inherited Metabolic Disease, Duran M, 2022.
